Discontinued — last reported Q4 '25
Johnson & Johnson R&D increased by 4.4% to $3.67B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 25.8%, from $4.95B to $3.67B. Over 2 years (FY 2021 to FY 2024), R&D shows an upward trend with a 19.0% CAGR.
High spending signals a focus on long-term innovation, though it reduces current-period net income.
Expenses related to the innovation, design, and improvement of products and services. In the technology sector, this rep...
Big Tech firms often reinvest a significant percentage of revenue into R&D to maintain market leadership.
is_research_and_development| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.18B | $3.39B | $3.42B | $3.84B | $3.46B | $3.70B | $3.60B | $3.56B | $3.45B | $3.54B | $3.44B | $4.95B | $5.30B | $3.23B | $3.52B | $3.67B |
| QoQ Change | — | +6.8% | +0.8% | +12.2% | -9.9% | +7.0% | -2.9% | -0.9% | -3.3% | +2.8% | -2.9% | +44.0% | +7.0% | -39.1% | +9.0% | +4.4% |
| YoY Change | — | — | — | — | +8.9% | +9.1% | +5.1% | +2.9% | -6.9% | — | -3.5% | +43.7% | — | -8.9% | +2.2% | -25.8% |
We use cookies for analytics. See our Privacy and Cookie Policy.